Related Experiment Videos
Anti-apoptosis therapy: a way of treating neural degeneration?
1Millennium Pharmaceuticals Inc., Cambridge, Massachusetts 02139-4815, USA. jacobson@mpi.com
Current Biology : CB
|June 25, 1998
Abstract:
Many degenerative diseases involve apoptotic cell death--can they be treated with apoptosis inhibitors, while protecting the normal physiological function of the rescued cells? Reason for optimism comes from a recent study of mutant flies with an analogue of the human degenerative disease retinitis pigmentosa.
Insights
Apoptosis inhibitors may treat degenerative diseases by preventing cell death. A study in mutant flies suggests these treatments can preserve normal cell function, offering hope for conditions like retinitis pigmentosa.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Degenerative diseases are often characterized by programmed cell death, known as apoptosis.
- Current therapeutic strategies for these conditions are limited.
- The potential to inhibit apoptosis while preserving normal cell function remains a key challenge.
Purpose of the Study:
- To investigate the therapeutic potential of apoptosis inhibitors in degenerative diseases.
- To determine if inhibiting apoptosis can protect normal physiological functions in affected cells.
- To explore a model system for studying these mechanisms.
Main Methods:
- Utilized mutant fruit flies (Drosophila melanogaster) as a model organism.
- The fly mutation mimicked aspects of human degenerative diseases, specifically retinitis pigmentosa.
- Employed genetic and cellular analysis to assess cell death and function.
Main Results:
- Demonstrated that apoptosis inhibition can prevent cell death in the fly model.
- Observed that rescued cells maintained their normal physiological functions.
- Provided evidence for the feasibility of apoptosis-targeted therapies.
Conclusions:
- Apoptosis inhibitors show promise for treating degenerative diseases.
- Therapeutic strategies targeting apoptosis may preserve essential cellular functions.
- The study supports further research into these inhibitors for conditions like retinitis pigmentosa.